Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: A phoP::Tn10 mutant does not suppress but does protect

Vaccine

Volumn 16, Issue 1, 1998, Pages 24-32

  Eisenstein, Toby K ^a   Meissler Jr , Joseph J ^a   Miller, Samuel I ^b   Stocker, Bruce A D ^c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; NITRIC OXIDE; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INOCULATION; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SHEEP ERYTHROCYTE; SPLEEN CELL;

ANIMALS; BACTERIAL VACCINES; FEMALE; MICE; MICE, INBRED C3H; NITRIC OXIDE; SALMONELLA; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SPLEEN; VACCINES, ATTENUATED;

EID: 0031986420     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00160-6     Document Type: Article

References (42)

1. Ashcroft M.T., Ritchie J.M., Nicholson C.C. Controlled field trial in British Guiana school children of heat-killed phenolized and acetone-killed lyophilized typhoid vaccines. Am. J. Hyg. 79:1964;196-206.
2. Acharya I.L., Lowe C.U., Thapa R.et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. N. Engl. J. Med. 317:1987;1101-1104.
3. Klugman K., Gilberson I.T., Koornhof H.J.et al. Vaccination advisory committee: Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet. 2:1987;1165-1169.
4. Wahdan M.H., Serie C., Cerisier Y., Sallam S., Germanier R. A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: Three-year results. J. Infect. Dis. 145:1982;292-295.
5. Curtiss, R., Attenuated Salmonella strains as live vectors for the expression of foreign antigens. In New Generation Vaccines, ed. G.C. Woodrow and M.M. Levine, Marcel Dekker, New York, 1990, pp. 161-188.
6. Doggett, T.A. and Curtiss, R. Delivery of antigens by recombinant avirulent Salmonella strains.In Advances in Experimental Medicine and Biology, ed. J.E. Cirardi, J.R. McGhee and J.M. Keith, Volume 327, Plenum Press, New York, 1992, pp. 165-173.
7. Chatfield S., Roberts M., Londono P., Cropley I., Douce G., Dougan G. The development of oral vaccines based on live attenuated Salmonella strains. FEMS. Immunol. Med. Microb. 7:1993;1-8.
8. Hoiseth S.K., Stocker B.A.D. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 291:1981;238-239.
9. Levine, M.M. and Hone, D.M., Typhoid fever. In Vaccines and Immunotherapy, ed. S.J.J. Cryz, Pergamon Press, New York, 1991, pp. 59-72.
10. Eisenstein T.K., Sultzer B.M. Immunity to Salmonella infection. Adv. Exp. Med. Biol. 162:1983;261-296.
11. Lee J.C., Gibson C.W., Eisenstein T.K. Macrophage-mediated mitogenic suppression induced in mice of the C3H lineage by a vaccine strain of Salmonella typhimurium. Cell. Immunol. 91:1985;75-91.
12. Al-Ramadi B.K., Brodkin M.A., Mosser D.M., Eisenstein T.K. Immunosuppression induced by attenuated Salmonella. Evidence for mediation by macrophage precursors. J. Immunol. 146:1991;2737-2746.
13. Deschenes M., Guenounou E., Ronco F., Vacheron F., Nauciel C. Impairment of lymphocyte proliferative responses and interleukin-2 production in susceptible (C57BL/6) mice infected with Salmonella typhimurium. Immunology. 58:1986;225-230.
14. Al-Ramadi B.K., Chen Y.W., Meissler J.J. Jr., Eisenstein T.K. Immunosuppression induced by attenuated Salmonella. Reversal by IL-4. J. Immunol. 147:1991;1954-1961.
15. Al-Ramadi B.K., Greene J.M., Meissler J.J. Jr., Eisenstein T.K. Immunosuppression induced by attenuated Salmonella: effect of LPS responsiveness on development of suppression. Microb. Pathog. 12:1992;267-278.
16. Al-Ramadi B.K., Meissler J.J. Jr., Huang D., Eisenstein T.K. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22:1992;2249-2254.
17. Huang D., Schwacha M.G., Eisenstein T.K. Attenuated salmonella vaccine induced suppression of murine spleen cell mitogen responses is mediated by macrophage nitric oxide: Quantitative aspects. Infect. Immun. 64:1996;3786-3792.
18. Eisenstein T.K., Dalal N., Killar L., Lee J.C., Schafer R. Paradoxes of immunity and immunosuppression in Salmonella infection. Adv. Exp. Med. Biol. 239:1988;353-366.
19. Eisenstein T.K., Killar L.M., Stocker B.A., Sultzer B.M. Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/HeJ mice. J. Immunol. 133:1984;958-961.
20. Killar L.M., Eisenstein T.K. Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine. Infect. Immun. 47:1985;605-612.
21. Eisenstein T.K., Deakins L.W., Killar L., Saluk P.H., Sultzer B.M. Dissociation of innate susceptibility to Salmonella infection and endotoxin responsiveness in C3HeB/FeJ mice and other strains in the C3H lineage. Infect. Immun. 36:1982;696-703.
22. Eisenstein T.K., Killar L.M., Sultzer B.M. Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. J. Infect. Dis. 150:1984;425-435.
23. Smith B.P., Reina-Guerra M., Stocker B.A., Hoiseth S.K., Johnson E. Aromatic-dependent Salmonella dublin as a parenteral modified live vaccine for calves. Am. J. Vet. Res. 45:1984;2231-2235.
24. Edwards M.F., Stocker B.A.D. Construction of DaroA his Dpur strains of Salmonella typhi. J. Bacteriol. 170:1988;3991-3995.
25. Curtiss R., Kelly S.M. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55:1987;3035-3043.
26. Hone D., Morona R., Attridge S., Hackett J. Construction of defined galE mutants of Salmonella for use as vaccines. J. Infect. Dis. 156:1987;167-174.
27. Hormaeche C.E., Pettifor R.A., Brock J. The fate of temperature-sensitive Salmonella mutants in vivo in naturally resistant and susceptible mice. Immunology. 42:1981;569-576.
28. Gunn J.S., Hohmann E.L., Miller S.I. Transcriptional regulation of Salmonella virulence: a PhoQ periplasmic domain mutation results in increased net phosphotransfer to PhoP. J. Bacteriol. 178:1996;6369-6373.
29. Miller S.I., Kukral A.M., Mekalanos J.J. A two component regulatory system (phoP and phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. USA. 86:1989;5054-5058.
30. Miller S.I., Mekalanos J.J. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J. Bacteriol. 172:1990;2485-2490.
31. 15N)nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
32. Mishell R.I., Dutton R.W. Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126:1967;423.
33. Cunningham A., Szenberg A. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology. 14:1968;599-600.
34. Bliss, C.J., Statistics in Biology, McGraw-Hill, New York, 1967, pp. 63-65.
35. Eisenstein T.K., Huang D., Meissler J.J. Jr., al-Ramadi B. Macrophage nitric oxide mediates immunosuppression in infectious inflammation. Immunobiology. 191:1994;493-502.
36. Galan J.E., Curtiss R. III Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb. Pathog. 6:1989;433-443.
37. Hohmann E.L., Oletta C.A., Killeen K.P., Miller S.I. phoP/phoQ-Deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Dis. 173:1996;1408-1414.
38. Wick M.J., Harding C.V., Twesten N.J., Normark S.J., Pfeifer J.D. The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages. Mol. Microbiol. 16:1995;465-476.
39. Guo L., Lim K.B., Gunn J.S.et al. Regulation of Lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science. 276:1997;250-253.
40. Collins F.M., Mackaness G.B., Blanden R.V. Infection-immunity in experimental salmonellosis. J. Exp. Med. 124:1966;601-619.
41. O'Callaghan D., Maskell D., Tite J., Dougan G. Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains. Immunology. 69:1990;184-189.
42. Levine M.M., Herrington D., Murphy J.R.et al. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in man. J. Clin. Invest. 79:1987;888-902.